Albert Labs has announced Sara Tai, Senior Lecturer in Clinical Psychology from Manchester University, as Principal Investigator for its upcoming trial. The trial will evaluate the safety and efficacy of KRN-101, a psilocybin-based medicine, for the treatment of cancer-related distress.
Compound Psilocybin
Visit article
Category Press Release
Published in Yahoo Finance
Companies Featured
Albert LabsAlbert Labs is a publicly listed company (CSE) that uses Real-World Evidence (RWE) to accelerate the psychedelic drug development process.